A Pharmacokinetic Subtrial in Adolescent Patients With Hereditary Angioedema Type I or II Participating in the KVD900-302 Trial
A Pharmacokinetic Subtrial in Adolescent Patients With Hereditary Angioedema Type I or II Participating in the KVD900-302 Trial
This is a multicenter pharmacokinetic (PK) subtrial to investigate the PK profile of KVD900 (sebetralstat) in adolescent patients 12 to 17 years of age with Hereditary Angioedema (HAE) type I or II.
Inclusion Criteria:
Exclusion Criteria:
Petach Tikvah, 4920235, Israel
Kawagoe-shi, 350-8550, Japan
Soka-shi, 340-0041, Japan
Takatsuki-shi, 569-8686, Japan